Standardized Criteria for Measuring Severe Maternal Morbidity in Placenta Accreta Spectrum Disorder

Brett D Einerson1, Sarah Rae Easter, Daniela Carusi

  • 1Division of Maternal-Fetal Medicine, University of Utah Health, Salt Lake City, Utah; the Division of Maternal-Fetal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; the Department of Anesthesiology, University of California, San Francisco, San Francisco, and the Division of Maternal-Fetal Medicine, Stanford University, Stanford, California; the Division of Gynecologic Oncology, Columbia University College of Physicians and Surgeons, New York, New York; the EGA Institute for Women's Health, Faculty of Population Health Sciences, University College London, London, United Kingdom; the Department of Obstetrics and Gynecology, Bordeaux University Hospital, Bordeaux, France; the Department of Obstetrics and Gynaecology, University of Toronto and Mount Sinai Hospital, Toronto, Ontario, Canada; and the Division of Maternal-Fetal Medicine, University of Virginia, Charlottesville, Virginia.

PubMed
Summary

Standardized criteria for severe maternal morbidity and mortality (SMM) in placenta accreta spectrum (PAS) are proposed. This aims to improve research by distinguishing complications from interventions, aiding evidence-based care.

Related Concept Videos